Ucb Sa

Reporting payments is a legal requirement; large totals often reflect large product portfolios.

$7.3Mgeneral payments (2019-2025)
$1.3Mresearch payments (2019-2025)
1,394clinicians paid

General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.

General payments by year

2019 $603K
2020 $1.0M
2021 $924K
2022 $825K
2023 $1.3M
2024 $1.1M
2025 $1.5M

General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.

Products most associated with its payments

Specialties it works with most

Neurology (Psychiatry & Neurology) $1.7M
Rheumatology $982K
Dermatology $942K
Pediatrics $914K
Hypertension Specialist $354K
Neurology With Special Qualifications In Child Neurology $281K

Clinicians with the largest reported totals

Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.

ClinicianLocationSpecialtyGeneral payments (2019-2025)
Jan Berger Chicago, IL Pediatrics $819,648.77
William White Farmington, CT Hypertension Specialist $354,060.00
Kevin Winthrop Portland, OR Infectious Disease $203,445.00
Pushpa Narayanaswami Boston, MA Neurology (Psychiatry & Neurology) $200,483.68
John Hixson San Francisco, CA Neurology (Psychiatry & Neurology) $175,000.00
Peter Kowey Wynnewood, PA Cardiovascular Disease $174,300.00
Victor Sloan New Brunswick, NJ Rheumatology $138,623.76
Maria Abreu West Hollywood, CA Gastroenterology (Internal Medicine) $130,645.00
Atulya Deodhar Portland, OR Rheumatology $112,791.60
Bruce Strober Cromwell, CT Dermatology $100,257.23

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.